Differentiation of Tubular Adenoma and Colonic Innominate Groove Under EC Endoscopy
1 other identifier
observational
96
1 country
1
Brief Summary
This study is to analyze the characteristics of the IIIL opening of the duct in tubular adenoma and the colonic innominate groove under EC endoscopy, in order to improve the ability to tell lesions and the colonic innominate groove under EC endoscopy (Endocytoscopy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
March 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedApril 12, 2024
April 1, 2024
6 months
August 23, 2023
April 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of opening length to field of view
(more than 1 field of view is calculated as 1.0)
10 minutes after the observation of Endocytoscopy
Secondary Outcomes (1)
Observation of anatomical location
10 minutes after the observation of Endocytoscopy
Other Outcomes (2)
Morphology of IIIL type glandular opening and unnamed sulcus opening
10 minutes after the observation of Endocytoscopy
Distribution characteristics of glandular opening
10 minutes after the observation of Endocytoscopy
Study Arms (2)
The tubular adenoma group
The anatomical site was determined, and the size and morphology of the polyps were observed. The classification of the microvascular ECV of the polyps and its adjacent normal mucosal microvascular ECV (white light+NBI) was observed, and methylene blue staining was used to approach and magnify the glandular duct opening to observe the IIIL type (pit pattern). Magnified to the maximum magnification of EC endoscopy to the clearest cell level (approximately 520 times), and observed the morphology of the opening of the IIIL type glandular duct and the opening of the colonic innominate groove, including the morphology of cell cytoplasm and nucleus, proportion of opening length to field of view (more than 1 field of view is calculated as 1.0), and ratio of maximum to minimum opening diameter; Distribution characteristics of glandular duct openings.
the colonic innominate groove group
The methylene blue staining area of the normal mucosa adjacent to the polyp was observed to identify the colonic innominate groove.Magnified to the maximum magnification of EC endoscopy to the clearest cell level (approximately 520 times), and observed the morphology of the opening of the IIIL type glandular duct and the opening of the colonic innominate groove, including the morphology of cell cytoplasm and nucleus, proportion of opening length to field of view (more than 1 field of view is calculated as 1.0), and ratio of maximum to minimum opening diameter; Distribution characteristics of glandular duct openings.
Interventions
Biopsy or removal of polyps for pathological examination. Collect baseline data such as gender, age, BMI, etc. If the pathology confirms a pure tubular adenoma, the observed object will be included in the group for final comparative analysis.
Eligibility Criteria
Cases of colorectal polyps discovered in our hospital and undergoing EC endoscopic examination.
You may qualify if:
- Cases of colorectal polyps discovered in our hospital and undergoing EC endoscopic examination.
You may not qualify if:
- Suffering from hereditary polyposis or inflammatory bowel disease, severe intestinal inflammation, or difficulty recognizing normal intestinal mucosa;
- \. History of methylene blue allergy;
- \. Patients who have participated or are currently participating in other clinical trials within the first 4 weeks of enrollment;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jilin Universitylead
Study Sites (1)
the First Hospital of Jilin University
Changchun, Jilin, 130021, China
Central Study Contacts
Dong Yang, doctor
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisted Investigator
Study Record Dates
First Submitted
August 23, 2023
First Posted
October 10, 2023
Study Start
March 26, 2024
Primary Completion
September 30, 2024
Study Completion
December 30, 2024
Last Updated
April 12, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share